EML4 and non-small cell lung carcinoma: A study examined the role of ALK rearrangement in affecting PD-L1 expression, their result showed that EML4-ALK fusion could decrease the PD-L1 expression through suppression of PI3K–AKT or MEK–ERK signaling pathway, which contributes to the immune escape in NSCLC (87).